Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 21, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uniqure N.V.
| 8.08K |
—
|
—
| +39.90% | 28.33K |
Jun 19
| |||||||
Uniqure N.V.
| -2.23K |
$5.12 | -$11,412.48 | -9.92% | 20.25K |
Jun 13
| |||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 4
| |||||||
Cullinan Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 15
| |||||||
Cullinan Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 16
| |||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Uniqure N.V.
| 6.41K |
$18.85 | -$43,166.50 | +39.89% | 22.48K |
Jun 13 - Jun 16
| |||||||
Uniqure N.V.
| -389.00 |
$19.71 | -$7,667.19 | -2.36% | 16.07K |
Feb 27
| |||||||
Mirati Therapeutics, Inc.
| 89.38K |
—
|
—
| +144.64% | 151.17K |
Jan 20
| |||||||
Mirati Therapeutics, Inc.
| -3.18K |
$42.38 | -$134,714.58 | -4.89% | 61.79K |
Jan 17
| |||||||
Mirati Therapeutics, Inc.
| 30.81K |
$40.41 | -$186,551.95 | +90.19% | 64.97K |
Dec 19 - Dec 21
| |||||||
Entasis Therapeutics Holdings Inc.
| -49.50K |
$2.20 | -$108,900.00 | -100.00% |
0
|
Jul 7 - Jul 11
| |||||||
Uniqure N.V.
| 9.08K |
—
|
—
| +123.04% | 16.46K |
Jun 15
| |||||||
Uniqure N.V.
| -602.00 |
$16.70 | -$10,053.40 | -7.54% | 7.38K |
Feb 28
| |||||||
Uniqure N.V.
| 1.53K |
—
|
—
| +23.79% | 7.98K |
Feb 24
| |||||||
Entasis Therapeutics Holdings Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 16
| |||||||
Entasis Therapeutics Holdings Inc.
| 27.5K |
—
|
—
| +125.00% | 49.5K |
Jan 18
| |||||||
Mirati Therapeutics, Inc.
| 34.06K |
—
|
—
|
∞
| 34.06K |
Jan 14
| |||||||
Mirati Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 22
| |||||||
Mirati Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Entasis Therapeutics Holdings Inc.
| 22K |
—
|
—
|
∞
| 22K |
Apr 1
| |||||||
Uniqure N.V.
| -505.00 |
$37.50 | -$18,937.50 | -7.26% | 6.45K |
Mar 2
| |||||||
Uniqure N.V.
| 2.38K |
—
|
—
| +52.11% | 6.95K |
Feb 25
| |||||||
Entasis Therapeutics Holdings Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Uniqure N.V.
| 2.06K |
—
|
—
| +82.26% | 4.57K |
Feb 27
| |||||||
Uniqure N.V.
| -722.00 |
$62.19 | -$44,903.36 | -22.35% | 2.51K |
Jan 28
| |||||||
Entasis Therapeutics Holdings Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
Entasis Therapeutics Holdings Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Uniqure N.V.
| 3.23K |
—
|
—
|
∞
| 3.23K |
Jan 25
| |||||||
Uniqure N.V.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Uniqure N.V.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Baxalta Inc
| -51.64K |
—
|
—
| -100.00% |
0
| +1 |
Jun 3
| ||||||
Baxalta Inc
| 27.05K |
$39.30 | -$36,470.40 | +110.23% | 51.59K | +1 |
Mar 3
| ||||||
Baxalta Inc
| -791.00 |
$35.03 | -$27,708.73 | -3.16% | 24.28K | +1 |
Sep 2
| ||||||
Baxalta Inc
| 25.07K |
—
|
—
|
∞
| 25.07K | +1 |
Jul 1
| ||||||
Baxalta Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Endocyte Inc
| 7.5K |
—
|
—
|
∞
| 7.5K |
Feb 6
| |||||||
Endocyte Inc
|
0
|
$12.12 | -$67,700.00 |
—
|
0
|
Sep 12
| |||||||
Endocyte Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 19
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.